| ELAC2/HPC2 involvement in hereditary and sporadic prostate cancer. |
| Rkman A, Ikonen T, Mononen N, Autio V, Matikainen MP, Koivisto PA, Tammela TL, Kallioniemi OP, Schleutker J |
| Cancer research. 2001 ; 61 (16) : 6038-6041. |
| PMID 11507049 |
| |
| Polymorphisms in the prostate cancer susceptibility gene HPC2/ELAC2 in multiplex families and healthy controls. |
| Suarez BK, Gerhard DS, Lin J, Haberer B, Nguyen L, Kesterson NK, Catalona WJ |
| Cancer research. 2001 ; 61 (13) : 4982-4984. |
| PMID 11431329 |
| |
| A candidate prostate cancer susceptibility gene at chromosome 17p. |
| Tavtigian SV, Simard J, Teng DH, Abtin V, Baumgard M, Beck A, Camp NJ, Carillo AR, Chen Y, Dayananth P, Desrochers M, Dumont M, Farnham JM, Frank D, Frye C, Ghaffari S, Gupte JS, Hu R, Iliev D, Janecki T, Kort EN, Laity KE, Leavitt A, Leblanc G, McArthur-Morrison J, Pederson A, Penn B, Peterson KT, Reid JE, Richards S, Schroeder M, Smith R, Snyder SC, Swedlund B, Swensen J, Thomas A, Tranchant M, Woodland AM, Labrie F, Skolnick MH, Neuhausen S, Rommens J, Cannon-Albright LA |
| Nature genetics. 2001 ; 27 (2) : 172-180. |
| PMID 11175785 |
| |
| Role of HPC2/ELAC2 in hereditary prostate cancer. |
| Wang L, McDonnell SK, Elkins DA, Slager SL, Christensen E, Marks AF, Cunningham JM, Peterson BJ, Jacobsen SJ, Cerhan JR, Blute ML, Schaid DJ, Thibodeau SN |
| Cancer research. 2001 ; 61 (17) : 6494-6499. |
| PMID 11522646 |
| |
| Association of common missense changes in ELAC2 ( HPC2) with prostate cancer in a Japanese case-control series. |
| Fujiwara H, Emi M, Nagai H, Nishimura T, Konishi N, Kubota Y, Ichikawa T, Takahashi S, Shuin T, Habuchi T, Ogawa O, Inoue K, Skolnick MH, Swensen J, Camp NJ, Tavtigian SV |
| Journal of human genetics. 2002 ; 47 (12) : 641-648. |
| PMID 12522685 |
| |
| Assigning function to yeast proteins by integration of technologies. |
| Hazbun TR, Malmstrm L, Anderson S, Graczyk BJ, Fox B, Riffle M, Sundin BA, Aranda JD, McDonald WH, Chiu CH, Snydsman BE, Bradley P, Muller EG, Fields S, Baker D, Yates JR 3rd, Davis TN |
| Molecular cell. 2003 ; 12 (6) : 1353-1365. |
| PMID 14690591 |
| |
| Global analysis of protein localization in budding yeast. |
| Huh WK, Falvo JV, Gerke LC, Carroll AS, Howson RW, Weissman JS, O'Shea EK |
| Nature. 2003 ; 425 (6959) : 686-691. |
| PMID 14562095 |
| |
| The product of the candidate prostate cancer susceptibility gene ELAC2 interacts with the gamma-tubulin complex. |
| Korver W, Guevara C, Chen Y, Neuteboom S, Bookstein R, Tavtigian S, Lees E |
| International journal of cancer. Journal international du cancer. 2003 ; 104 (3) : 283-288. |
| PMID 12569551 |
| |
| A candidate prostate cancer susceptibility gene encodes tRNA 3' processing endoribonuclease. |
| Takaku H, Minagawa A, Takagi M, Nashimoto M |
| Nucleic acids research. 2003 ; 31 (9) : 2272-2278. |
| PMID 12711671 |
| |
| The N-terminal half-domain of the long form of tRNase Z is required for the RNase 65 activity. |
| Takaku H, Minagawa A, Takagi M, Nashimoto M |
| Nucleic acids research. 2004 ; 32 (15) : 4429-4438. |
| PMID 15317868 |
| |
| Characterization of TRZ1, a yeast homolog of the human candidate prostate cancer susceptibility gene ELAC2 encoding tRNase Z. |
| Chen Y, Beck A, Davenport C, Chen Y, Shattuck D, Tavtigian SV |
| BMC molecular biology. 2005 ; 6 (1) : page 12. |
| PMID 15892892 |
| |
| ELAC2, a putative prostate cancer susceptibility gene product, potentiates TGF-beta/Smad-induced growth arrest of prostate cells. |
| Noda D, Itoh S, Watanabe Y, Inamitsu M, Dennler S, Itoh F, Koike S, Danielpour D, ten Dijke P, Kato M |
| Oncogene. 2006 ; 25 (41) : 5591-5600. |
| PMID 16636667 |
| |